title: Reply to Sławomir Poletajew, Piotr Radziszewski, Juan Palou's Letter to the Editor re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52.
authors.affiliation: Radboud University Medical Centre, Nijmegen, The Netherlands.
authors.forename: Tom J H
authors.initials: TJ
authors.lastname: Arends
authors.affiliation: Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: Fred.witjes@radboudumc.nl.
authors.forename: J Alfred
authors.initials: JA
authors.lastname: Witjes
mesh_terms: D000276:Adjuvants, Immunologic; D000283:Administration, Intravesical; D001500:BCG Vaccine; D001407:Bacillus; D006801:Humans; D016685:Mitomycin; D001749:Urinary Bladder Neoplasms
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D016685:Mitomycin